Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2020

Mar 16, 2020

59231_rns_2020-03-16_c8cbad2b-6263-41f1-99b8-2bba46216892.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

BSE Limited National Stock Exchange of India Limited
Corporate Relations Department Listing Department
P J Towers, Exchange Plaza
Dalai Street Bandra Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 532300 NSE Svmbol - WOCKPHARMA

Dear Sirs / Madam,

This is with reference to your communication dated 13th March, 2020 about shares price movement of the Company.

In this regard, we have to inform you that the Company has been making prompt disclosures of all events or information that have bearing on the operation / performance of the Company which includes all price sensitive information as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

We understand that the recent movement in the share price of the Company may be due to ongoing market condition. At this point of time, the Company does not have any specific information/ announcement which have a bearing on the price or volume behavior of the scrip. Please note that the Company submits the requisite disclosures to the Stock Exchanges and shall continue to do so as part of its obligation under Regulation 30 of the SEBI Listing Regulations or other relevant applicable laws.

Kindly take the same on record.

Thanking you,

for Wockhardt

Narendra Si Company Secretary

WOCKHARDT LIMITED » Global I loadquarters: Woc.khardt Towers, Bandra Kurla Complex, Mumbai-400051, India • T: 9! 22-26534444 F; 91 • 22-26523905 ♦ Rogd Office: D-4 MIDC, Chitwlibana, Aurangabad-431006, India *T: 91-240-6632222 « F: 91 -240-2469219 www.wockhtiri4t.com < OH; I 24?30MH19991)i 0 20720